|
JPH0250488A
(ja)
*
|
1988-08-11 |
1990-02-20 |
Nec Corp |
超伝導配線
|
|
MXPA02012254A
(es)
*
|
2000-06-23 |
2003-04-25 |
American Cyanamid Co |
Montaje de particulas quimericas semejantes al virus de influenza y del tipo silvestre.
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US20060088909A1
(en)
*
|
2002-05-17 |
2006-04-27 |
Compans Richard W |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
EP1534344A4
(en)
*
|
2002-06-26 |
2008-05-28 |
Advanced Bionutrition Corp |
VIRUSES AND VIRUSIC PARTICLES FOR MULTIPLE ANTIGEN AND TARGET DISPLAY
|
|
ES2217967B1
(es)
*
|
2003-03-31 |
2006-01-01 |
Consejo Sup. Investig. Cientificas |
Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
|
|
CN1833030B
(zh)
|
2003-05-22 |
2014-07-23 |
美国弗劳恩霍夫股份有限公司 |
用于表达、传递及纯化目标多肽的重组载体分子
|
|
AU2011218606B2
(en)
*
|
2003-07-11 |
2012-01-12 |
Novavax, Inc |
Functional influenza virus-like particles (VLPS)
|
|
US8592197B2
(en)
*
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US8992939B2
(en)
|
2003-07-11 |
2015-03-31 |
Novavax, Inc. |
Highly efficient influenza matrix (M1) proteins
|
|
US8506967B2
(en)
|
2003-07-11 |
2013-08-13 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
US8551756B2
(en)
*
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
ES2307345B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
ES2307346B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
EP1766034B1
(en)
*
|
2004-05-21 |
2014-03-19 |
Novartis Vaccines and Diagnostics, Inc. |
Alphavirus vectors for influenza virus vaccines
|
|
CA2597928A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Lentigen Corporation |
Lentiviral vectors and their use
|
|
ES2310062B1
(es)
|
2005-07-15 |
2009-11-13 |
Bionostra, S.L. |
Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
|
|
BRPI0614475B8
(pt)
|
2005-08-03 |
2021-05-25 |
Fraunhofer Usa Inc |
polipeptídeo, anticorpo, ácido nucleico, vetores, célula hospedeira, composição e processos de produção de anticorpo
|
|
AU2006304640B2
(en)
*
|
2005-10-18 |
2012-10-11 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
TWI531652B
(zh)
|
2005-12-02 |
2016-05-01 |
美國紐約大學西奈山醫學院 |
表現非原生表面蛋白質之嵌合病毒及其用途
|
|
ATE552846T1
(de)
|
2005-12-06 |
2012-04-15 |
Yeda Res & Dev |
Verbesserter grippeimpfstoff
|
|
JP5198290B2
(ja)
*
|
2006-02-02 |
2013-05-15 |
グローブイミューン，インコーポレイテッド |
免疫反応を誘発する酵母ベースワクチン
|
|
US8277816B2
(en)
*
|
2006-02-13 |
2012-10-02 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
|
AU2007215080A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
|
US20080279877A1
(en)
*
|
2006-02-13 |
2008-11-13 |
Fraunhofer U.S.A. Inc. |
HPV antigens, vaccine compositions, and related methods
|
|
US20070224205A1
(en)
*
|
2006-03-07 |
2007-09-27 |
Powell Thomas J |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2007126788A2
(en)
*
|
2006-03-27 |
2007-11-08 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the treatment and prevention of viral infection
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US9101578B2
(en)
*
|
2006-05-01 |
2015-08-11 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (VLP) compositions
|
|
WO2007130327A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Influenza virus-like particle (vlp) compositions
|
|
KR100702034B1
(ko)
*
|
2006-05-12 |
2007-03-30 |
삼성전자주식회사 |
반도체 장치, 이 장치의 전원 노이즈 감소 방법 및 인쇄회로 기판
|
|
WO2007144886A2
(en)
|
2006-06-15 |
2007-12-21 |
Ben-Gurion University Of The Negev Research And Development Authority |
Virus-like particles for treatment of viral infections
|
|
US20100184832A1
(en)
|
2006-07-14 |
2010-07-22 |
Sanofi Pasteur Biologics Co. |
Construction of Recombinant Virus Vaccines by Direct Transposon-Mediated Insertion of Foreign Immunologic Determinants into Vector Virus Proteins
|
|
AU2007345768B2
(en)
*
|
2006-07-27 |
2013-08-01 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric influenza virus-like particles
|
|
EP2044224A4
(en)
*
|
2006-07-27 |
2011-04-13 |
Ligocyte Pharmaceuticals Inc |
CHIMERIC VIRUS TYPE PARTICLES
|
|
US20100239605A1
(en)
*
|
2006-09-29 |
2010-09-23 |
Sanofi Pasteur Biologics Co. |
Recombinant Rhinovirus Vectors
|
|
WO2008058396A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Folia Biotech Inc. |
Papaya mosaic virus-based vaccines for influenza
|
|
AU2007330494B2
(en)
*
|
2006-12-06 |
2014-03-13 |
Seqirus UK Limited |
Vaccines including antigen from four strains of influenza virus
|
|
US7998487B2
(en)
*
|
2007-02-16 |
2011-08-16 |
The Salk Institute For Biological Studies |
Antitoxin and vaccine platform based on nodavirus VLPs
|
|
BRPI0810865A2
(pt)
*
|
2007-04-28 |
2017-05-09 |
Fraunhofer Usa Inc |
antígenos de tripanossoma, composições vacinais, e métodos relacionados
|
|
WO2008148104A1
(en)
|
2007-05-25 |
2008-12-04 |
Novavax, Inc. |
Novel vlps derived from cells that do not express a viral matrix or core protein
|
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
PL2173376T3
(pl)
|
2007-08-02 |
2015-08-31 |
Biondvax Pharmaceuticals Ltd |
Multimeryczne wieloepitopowe szczepionki przeciwko grypie
|
|
CN101820903A
(zh)
*
|
2007-08-20 |
2010-09-01 |
美国弗劳恩霍夫股份有限公司 |
预防性和治疗性流感疫苗、抗原、组合物和方法
|
|
KR101956910B1
(ko)
*
|
2008-01-21 |
2019-03-12 |
메디카고 인코포레이티드 |
헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
|
|
JP2011519828A
(ja)
|
2008-04-18 |
2011-07-14 |
バクシネート コーポレーション |
フラジェリンの欠失変異体と使用方法
|
|
CA2742288A1
(en)
*
|
2008-07-30 |
2010-02-04 |
Folia Biotech Inc. |
Multivalent vaccines based on papaya mosaic virus and uses thereof
|
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
US9278126B2
(en)
|
2009-02-10 |
2016-03-08 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
AU2010243489A1
(en)
*
|
2009-05-01 |
2011-12-22 |
Redbiotec Ag |
Recombinant virus-like particles encoded by multi-gene vector
|
|
EP2427547A1
(en)
*
|
2009-05-08 |
2012-03-14 |
GlaxoSmithKline Biologicals S.A. |
Method for producing virus from cell culture involving homogenization
|
|
PL222497B1
(pl)
*
|
2009-06-26 |
2016-08-31 |
Inst Biochemii I Biofizyki Pan |
Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej
|
|
CA2766899C
(en)
|
2009-07-02 |
2021-05-04 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
|
WO2011041391A1
(en)
|
2009-09-29 |
2011-04-07 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
|
US20110097358A1
(en)
*
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
WO2011056899A2
(en)
|
2009-11-03 |
2011-05-12 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
|
|
AU2010343095B2
(en)
*
|
2009-12-28 |
2017-01-05 |
Sanofi Vaccine Technologies, S.A.S. |
Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof
|
|
EP2519539A4
(en)
*
|
2009-12-28 |
2013-11-13 |
Ligocyte Pharmaceuticals Inc |
METHODS FOR STABILIZING VIRUS-LIKE PARTICULATE SOLUTIONS BASED ON INFLUENZA-INFLUENZA-VIRUSED VIRUSES
|
|
US9352031B2
(en)
|
2010-02-18 |
2016-05-31 |
Technovax, Inc. |
Universal virus-like particle (VLP) influenza vaccines
|
|
CN102370976B
(zh)
*
|
2010-08-09 |
2014-06-11 |
中山大学 |
猪流感病毒和猪口蹄疫病毒的混合病毒样颗粒、制备方法和应用
|
|
CN102373184A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用
|
|
CN102373182A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性囊病混合病毒样颗粒、制备方法和应用
|
|
CN102373181B
(zh)
*
|
2010-08-09 |
2014-06-11 |
中山大学 |
猪流感病毒和猪蓝耳病病毒混合病毒样颗粒、制备方法和应用
|
|
CN102373183A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和新城疫混合病毒样颗粒、制备方法和应用
|
|
CA2811023A1
(en)
|
2010-09-21 |
2012-03-29 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
|
|
BR112013007946B1
(pt)
|
2010-10-04 |
2022-07-12 |
Massachusetts Institute Of Technology |
Composições farmacêuticas e imunogênicas compreendendo polipeptídeos de hemaglutinina
|
|
US9821051B1
(en)
|
2010-10-28 |
2017-11-21 |
Seqirus UK Limited |
Reducing hospitalization in elderly influenza vaccine recipients
|
|
CA2828068C
(en)
|
2011-02-22 |
2019-03-19 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
KR20140047069A
(ko)
*
|
2011-06-20 |
2014-04-21 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
계산에 최적화된 광범위 반응을 나타내는 ｈ１ｎ１ 인플루엔자를 위한 항원
|
|
WO2013019800A1
(en)
*
|
2011-08-01 |
2013-02-07 |
Emory University |
Vlps containing ligands and methods related thereto
|
|
ES2953393T3
(es)
*
|
2011-09-20 |
2023-11-10 |
Icahn School Med Mount Sinai |
Vacunas contra el virus de la influenza y sus usos
|
|
WO2013142329A1
(en)
|
2012-03-22 |
2013-09-26 |
Fraunhofer Usa, Inc. |
Virus -like particles comprising a matrix protein from a plant enveloped virus and uses thereof
|
|
BR112014023900A2
(pt)
|
2012-03-30 |
2020-11-24 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Polipeptídeo de hemaglutimina de influenza recombinante, molécula de ácido nucleicoisolada, vetor, célula isolada, partícula semelhante ao vírus da influenza, proteína de fusão, composição, e uso
|
|
TWI434933B
(zh)
*
|
2012-04-17 |
2014-04-21 |
Nat Univ Tsing Hua |
抗多型禽流感病毒之ｄｎａ疫苗及其組合物
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|
|
AU2013352179B2
(en)
*
|
2012-11-27 |
2017-12-21 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for H1N1 influenza
|
|
EP2934581B1
(en)
|
2012-12-18 |
2022-09-14 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
|
US10080792B2
(en)
|
2013-09-23 |
2018-09-25 |
Engen Bio, Inc. |
Influenza vaccine and therapy
|
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
|
KR101729387B1
(ko)
|
2015-04-17 |
2017-04-21 |
경희대학교 산학협력단 |
곤충세포 발현시스템을 이용한 인플루엔자 백신 소재 ｍ1-ｍ2-ｎａ-ｈａ 바이러스 유사 입자의 제조방법
|
|
WO2017041100A2
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
US10391163B2
(en)
*
|
2015-09-10 |
2019-08-27 |
Academia Sinica |
Bird flu vaccine combination comprising virus-like particles and novel adjuvants
|
|
EP3471767A4
(en)
|
2016-06-15 |
2020-01-15 |
Icahn School of Medicine at Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
|
CN110325202B
(zh)
*
|
2016-10-31 |
2023-10-31 |
佐治亚州立大学研究基金会公司 |
乙型肝炎病毒pre-S蛋白的病毒样颗粒
|
|
CN110662556A
(zh)
|
2017-03-09 |
2020-01-07 |
哈佛大学的校长及成员们 |
癌症疫苗
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化（ｐａｃｅ）を用いて塩基編集因子を進化させるための方法および組成物
|
|
EP3810634A4
(en)
|
2018-06-21 |
2022-07-27 |
Icahn School of Medicine at Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
WO2020051766A1
(zh)
|
2018-09-11 |
2020-03-19 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
|
MX2019014943A
(es)
|
2018-12-12 |
2020-08-06 |
Cambridge Tech Llc |
Vacuna universal contra la gripe.
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
EP3956349A1
(en)
|
2019-04-17 |
2022-02-23 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
JP2022536364A
(ja)
|
2019-06-13 |
2022-08-15 |
ザ ジェネラル ホスピタル コーポレイション |
操作されたヒト内在性ウイルス様粒子および細胞への送達のためのその使用方法
|
|
WO2022020800A2
(en)
|
2020-07-24 |
2022-01-27 |
The General Hospital Corporation |
Enhanced virus-like particles and methods of use thereof for delivery to cells
|
|
CN116063409A
(zh)
*
|
2022-09-09 |
2023-05-05 |
中山大学·深圳 |
一种乙型流感Mosaic重组蛋白、重组质粒及其构建方法和应用
|